Pfizer RSV vaccine protects older adults over two seasons

Pfizer RSV vaccine protects older adults over two seasons

Respiratory syncytial virus vial. Manjurul | Istock | Getty Images Pfizer‘s vaccine against respiratory syncytial virus maintained protection for older adults across two full seasons of the disease in an ongoing late-stage clinical trial, the company announced Thursday. The shot’s efficacy declined slightly compared with the levels of protection after one RSV season, but the … Read more

New pet drugs are looking a lot more like human medications

New pet drugs are looking a lot more like human medications

If you want to understand how different the human and animal medicine and vaccine industries have historically been, you don’t need to look much further than weight loss drugs. On the human side, Novo Nordisk and Eli Lilly struggled to meet the demand for Ozempic, Wegovy, Mounjaro and Zepbound, respectively, since introducing them, as the … Read more

Novavax (NVAX) earnings report Q4 2023

Novavax (NVAX) earnings report Q4 2023

Budrul Chukrut | Lightrocket | Getty Images Vaccine maker Novavax on Wednesday reported fourth-quarter revenue and earnings that missed Wall Street’s estimates and reiterated plans to cut costs as it fights to stay afloat.  Still, Novavax narrowed its losses in the quarter from the same period a year ago, even as demand for the biotech … Read more

Viking Therapeutics weight loss drug shows promising trial results

Viking Therapeutics weight loss drug shows promising trial results

Cr | Istock | Getty Images Shares of Viking Therapeutics soared more than 80% in premarket trading Tuesday after the company’s experimental weight loss drug showed promising initial results in a mid-stage trial.  Viking Therapeutics is one of several small obesity drugmakers hoping to enter the budding weight loss drug industry, which analysts say could … Read more

Zealand Pharma soars 32% after promising weight-loss drug results

Zealand Pharma soars 32% after promising weight-loss drug results

Vials move along a conveyor at the Novo Nordisk A/S production facilities in Hillerod, Denmark, on Monday, June 12, 2023. The success of Novo’s bestsellers Ozempic and Wegovy, drugs that help people lose significant amounts of weight, has created something of a gold rush in the pharma industry with about 40 companies developing products that … Read more

Sickle cell disease gene therapies Casgevy Lyfgenia insurance cost issues

Sickle cell disease gene therapies Casgevy Lyfgenia insurance cost issues

Blood sample of patient positive tested for sickle cell. Kitsawet Saethao | Istock | Getty Images The approval of two gene therapies to treat sickle cell disease has given hope to patients who suffer from the debilitating disease, which overwhelmingly affects Black people and people of color. Health officials now face a challenge in finding … Read more

Novavax to settle Gavi arbitration over canceled Covid shot purchase

Novavax to settle Gavi arbitration over canceled Covid shot purchase

A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March 21, 2022 in The Hague, Netherlands. Patrick Van Katwijk | Getty Images Novavax on Thursday said it will settle a bitter arbitration dispute with Gavi, a nongovernmental global vaccine organization, over a … Read more

Moderna (MRNA) earnings Q4 2023

Moderna (MRNA) earnings Q4 2023

Nikos Pekiaridis | Nurphoto | Getty Images Moderna on Thursday posted a surprise quarterly profit, in part boosted by deferred revenue, even as the company saw slumping sales from its Covid vaccine, its only marketable product.  The results cap a rocky year for the biotech company and other Covid vaccine makers, which all saw revenue plunge … Read more

AbbVie taps Robert Michael as CEO, succeeding Richard Gonzalez

AbbVie taps Robert Michael as CEO, succeeding Richard Gonzalez

Test tubes are seen in front of a displayed AbbVie logo in this illustration taken on May 21, 2021. Dado Ruvic | Reuters AbbVie on Tuesday said longtime executive Robert Michael will become the company’s new CEO, replacing Richard Gonzalez.  Michael, who is AbbVie’s president and chief operating officer, will become the company’s second-ever CEO … Read more

What you need to know about health coverage for new weight loss drugs

What you need to know about health coverage for new weight loss drugs

Many U.S. companies are grappling with health insurance coverage issues for workers when it comes to GLP-1 drugs for weight loss. Despite the hefty price tag — typically between $1,000 to $1,500 a month — consumers are clamoring for drugs like Novo Nordisk‘s Wegovy and Eli Lilly‘s Zepbound. This class of drugs, historically used to … Read more